Virios Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for various viral infections and related diseases

The company leverages its proprietary technology platform to identify and advance potential treatments that target the underlying mechanisms of viral pathogenesis. By prioritizing the advancement of drug candidates for conditions with significant unmet medical needs, Virios aims to improve patient outcomes and establish itself as a leader in the field of antiviral therapeutics. Their research efforts are centered on creating therapeutic options that can address complex viral-related disorders through a combination of scientific innovation and rigorous clinical development.